成像市场：按技术、按应用、按最终用户、按影像类型、按地区

成像市场规模预计将从 2023 年的 376.3 亿美元增加到 2030 年的 565.8 亿美元，预测期内年复合成长率为 6%。

报告范围		报告详情
基准年	2022年	2023年市场规模	376.3亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期年复合成长率	6.00%	2030年市场规模预测	565.8亿美元

图 1. 2023 年按地区分類的成像全球市场占有率(%)

成像是医疗图像的一个领域，可以视觉化大脑的结构和功能。它提供了对各种疾病和病症背后的神经过程和异常的宝贵见解。这项技术彻底改变了神经科学领域，并为我们对人类大脑的理解做出了重大贡献。

市场动态：

成像市场由多种因素驱动。首先，神经系统疾病的日益普及增加了对准确诊断工具的需求，从而导致了神经影像成像技术的采用。此外，磁振造影（MRI）、正子断层扫描（PET）和电脑断层扫描（CT）等影像技术的进步显着提高了脑部影像的解析度和准确性。影像设备的高成本以及相关的维护和运作成本限制了其可近性，特别是在发展中地区。此外，对某些影像方式（例如电脑断层扫描中的电离辐射暴露）安全性的担忧对市场成长构成了挑战。儘管如此，成像市场仍存在一些机会。增加对研发活动的投资，以开发功能性磁振造影（fMRI）和扩散张量影像（DTI）等先进影像技术，预计将推动市场成长。此外，对个人化医疗的日益关注以及人工智慧（AI）在成像中的整合为市场扩张提供了新的途径。

本研究的主要特点

• 本报告对全球成像市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（年复合成长率%）。
• 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
• 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
• 它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球成像市场的主要企业。
• 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
• 全球成像市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 透过用于分析全球成像市场的各种策略矩阵，将促进相关人员的决策。

目录

第1章调查目的和假设

• 这项研究的目的
• 假设
• 简称

第2章市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第3章市场动态、法规及趋势分析

• 市场动态
  • 影像技术的进步
  • 设备成本高
  • 个人化医疗
• 影响分析
• 主要亮点
• 法规场景
• 产品发布/核准
• PEST分析
• 波特的分析
• 併购场景

第4章成像市场－冠状病毒（COVID-19）大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第5章成像市场，依技术划分，2023-2030 年

• 磁振造影(MRI)
• 电脑断层扫描 (CT)
• 正子断层扫描 (PET)
• 单光子发射电脑断层扫描 (SPECT)
• 功能性磁振造影(fMRI)
• 扩散张量成像(DTI)
• 脑磁图（MEG）
• 脑电图（EEG）
• 其他的

第6章成像市场，依应用划分，2023-2030

• 神经系统疾病
• 阿兹海默症
• 帕金森氏症
• 多发性硬化症
• 癫痫
• 中风
• 其他的
• 精神障碍
• 思觉失调症
• 躁郁症
• 沮丧
• 焦虑症
• 其他的
• 创伤性脑损伤 (TBI)
• 脑肿瘤
• 其他的

第7章成像市场，依最终使用者划分，2023-2030 年

• 医院和诊所
• 医院和诊所
• 调查机构
• 门诊手术中心
• 其他的

第8章成像市场，依影像类型，2023-2030

• 构造成像
• 功能性成像
• 混合成像

第9章成像市场，按地区，2023-2030

• 北美洲
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东和非洲

第10章竞争形势

• GE Healthcare
• Philips Healthcare
• Toshiba Medical Systems Corporation
• Hitachi Healthcare
• Canon Medical Systems Corporation
• Mindray Medical International Limited
• Esaote SpA
• NeuroLogica Corporation
• Others

第11章章节

• 调查方法
• 关于出版商

The Neuroimaging Market size is expected to reach US$ 56.58 Billion by 2030, from US$ 37.63 Billion in 2023, at a CAGR of 6% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 37.63 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	6.00%	2030 Value Projection:	US$ 56.58 Bn

Figure 1. Global Neuroimaging Market Share (%), By Region, 2023

Neuroimaging is a branch of medical imaging that allows for the visualization of the structure and function of the brain. It provides valuable insights into the neurological processes and abnormalities that underlie various diseases and disorders. This technology has revolutionized the field of neuroscience and has contributed significantly to understanding of the human brain.

Market Dynamics:

The neuroimaging market is driven by several factors. Firstly, the growing prevalence of neurological disorders has increased the demand for accurate diagnostic tools, leading to the adoption of neuroimaging technologies. Moreover, the advancements in imaging technology, such as magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT), have significantly improved the resolution and accuracy of brain imaging.

However, the market also faces certain restraints. The high cost of neuroimaging equipment and the associated maintenance and operational costs limit its accessibility, especially in developing regions. Additionally, concerns regarding the safety of certain imaging modalities, such as ionizing radiation exposure in CT scans, pose challenges for market growth.

Nevertheless, the neuroimaging market presents several opportunities. The increasing investment in research and development activities to develop advanced imaging techniques, such as functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI), is expected to drive market growth. Moreover, the rising focus on personalized medicine and the integration of artificial intelligence (AI) in neuroimaging offer new avenues for market expansion.

Key features of the study:

• This report provides in-depth analysis of the global neuroimaging market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global neuroimaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include General Electric Company, Siemens Healthineers AG, and Philips Healthcare, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global neuroimaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroimaging market

Detailed Segmentation:

• By Technology:
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Functional Magnetic Resonance Imaging (fMRI)
  • Diffusion Tensor Imaging (DTI)
  • Magnetoencephalography (MEG)
  • Electroencephalography (EEG)
  • Others
• By Application:
  • Neurological Disorders
  • Alzheimer's Disease
  • Parkinson's Disease
  • Multiple Sclerosis
  • Epilepsy
  • Stroke
  • Others
  • Psychiatric Disorders
  • Schizophrenia
  • Bipolar Disorder
  • Depression
  • Anxiety Disorders
  • Others
  • Traumatic Brain Injury (TBI)
  • Brain Tumors
  • Others
• By End-User:
  • Hospitals and Clinics
  • Diagnostic Centers
  • Research Institutes
  • Ambulatory Surgical Centers
  • Others
• By Region:
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
• By Image Type:
  • Structural Imaging
  • Functional Imaging
  • Hybrid Imaging
• Top companies in Neuroimaging Market
  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Toshiba Medical Systems Corporation
  • Hitachi Healthcare
  • Canon Medical Systems Corporation
  • Mindray Medical International Limited
  • Esaote SpA
  • NeuroLogica Corporation
  • NeuroVive Pharmaceutical AG
  • Brainlab AG
  • Akili Interactive Labs Inc.
  • Brainomix Ltd.
  • Imaging Science International
  • Mevis Medical Solutions
  • NeuroVista
  • Neusoft Medical Systems
  • Positron Corporation
  • Shimadzu Corporation
  • Trifoil Imaging

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Technology
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Image Type
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Advancements in Imaging Technology
  • High Equipment Costs
  • Personalized Medicine
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Neuroimaging Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Neuroimaging Market , By Technology, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Magnetic Resonance Imaging (MRI)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Computed Tomography (CT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Positron Emission Tomography (PET)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Single Photon Emission Computed Tomography (SPECT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Functional Magnetic Resonance Imaging (fMRI)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Diffusion Tensor Imaging (DTI)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Magnetoencephalography (MEG)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Electroencephalography (EEG)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Neuroimaging Market , By Application, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Neurological Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Alzheimer's Disease
• Parkinson's Disease
• Multiple Sclerosis
• Epilepsy
• Stroke
• Others
• Psychiatric Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Schizophrenia
• Bipolar Disorder
• Depression
• Anxiety Disorders
• Others
• Traumatic Brain Injury (TBI)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Brain Tumors
• Others

7. Neuroimaging Market , By End User, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

8. Neuroimaging Market , By Image Type, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Structural Imaging
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Functional Imaging
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Hybrid Imaging
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

9. Neuroimaging Market , By Region, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2018 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)

10. Competitive Landscape

• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Philips Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Toshiba Medical Systems Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hitachi Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Canon Medical Systems Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Mindray Medical International Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Esaote SpA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• NeuroLogica Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Others
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

11. Section

• Research Methodology
• About us